nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—SLC6A2—autonomic nervous system—conduct disorder	0.119	0.313	CbGeAlD
Orphenadrine—GRIN2D—brain—conduct disorder	0.0348	0.0914	CbGeAlD
Orphenadrine—GRIN2D—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0342	0.0791	CbGpPWpGaD
Orphenadrine—GRIN3A—brain—conduct disorder	0.0327	0.0859	CbGeAlD
Orphenadrine—GRIN1—brain—conduct disorder	0.031	0.0815	CbGeAlD
Orphenadrine—Reboxetine—SLC6A4—conduct disorder	0.0277	0.148	CrCbGaD
Orphenadrine—GRIN1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0245	0.0566	CbGpPWpGaD
Orphenadrine—SCN9A—brain—conduct disorder	0.0243	0.0638	CbGeAlD
Orphenadrine—SCN4A—brain—conduct disorder	0.0216	0.0569	CbGeAlD
Orphenadrine—SCN1A—brain—conduct disorder	0.0209	0.0549	CbGeAlD
Orphenadrine—SCN10A—brain—conduct disorder	0.0185	0.0486	CbGeAlD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0176	0.0407	CbGpPWpGaD
Orphenadrine—Fluoxetine—SLC6A4—conduct disorder	0.0174	0.0927	CrCbGaD
Orphenadrine—SLC6A2—Monoamine Transport—SLC6A4—conduct disorder	0.0168	0.0389	CbGpPWpGaD
Orphenadrine—SCN5A—brain—conduct disorder	0.0168	0.0442	CbGeAlD
Orphenadrine—Cyclobenzaprine—HTR2A—conduct disorder	0.0146	0.0779	CrCbGaD
Orphenadrine—CHRM2—brain—conduct disorder	0.0143	0.0376	CbGeAlD
Orphenadrine—Fluoxetine—HTR2A—conduct disorder	0.0133	0.0712	CrCbGaD
Orphenadrine—Chlorphenamine—SLC6A4—conduct disorder	0.0133	0.0709	CrCbGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0132	0.0306	CbGpPWpGaD
Orphenadrine—Promazine—DRD4—conduct disorder	0.013	0.0691	CrCbGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0126	0.0291	CbGpPWpGaD
Orphenadrine—SLC6A2—brain—conduct disorder	0.0115	0.0302	CbGeAlD
Orphenadrine—Atomoxetine—SLC6A4—conduct disorder	0.0112	0.0595	CrCbGaD
Orphenadrine—HRH1—Monoamine GPCRs—DRD4—conduct disorder	0.0108	0.0249	CbGpPWpGaD
Orphenadrine—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.0106	0.0245	CbGpPWpGaD
Orphenadrine—KCNH2—brain—conduct disorder	0.0103	0.0271	CbGeAlD
Orphenadrine—GRIN2D—Neuronal System—GABRA2—conduct disorder	0.0101	0.0234	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00947	0.0219	CbGpPWpGaD
Orphenadrine—Trimipramine—SLC6A4—conduct disorder	0.00918	0.049	CrCbGaD
Orphenadrine—HRH1—Amine ligand-binding receptors—DRD4—conduct disorder	0.00905	0.0209	CbGpPWpGaD
Orphenadrine—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0089	0.0206	CbGpPWpGaD
Orphenadrine—Doxepin—SLC6A4—conduct disorder	0.00874	0.0467	CrCbGaD
Orphenadrine—Atomoxetine—HTR2A—conduct disorder	0.00857	0.0457	CrCbGaD
Orphenadrine—CYP2B6—brain—conduct disorder	0.00847	0.0223	CbGeAlD
Orphenadrine—HRH1—brain—conduct disorder	0.00827	0.0218	CbGeAlD
Orphenadrine—CYP2E1—brain—conduct disorder	0.00795	0.0209	CbGeAlD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00734	0.017	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—GABRA2—conduct disorder	0.00725	0.0168	CbGpPWpGaD
Orphenadrine—Trimipramine—HTR2A—conduct disorder	0.00705	0.0376	CrCbGaD
Orphenadrine—HRH1—Monoamine GPCRs—HTR2A—conduct disorder	0.00702	0.0162	CbGpPWpGaD
Orphenadrine—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.00691	0.016	CbGpPWpGaD
Orphenadrine—Imipramine—SLC6A4—conduct disorder	0.0068	0.0363	CrCbGaD
Orphenadrine—Promethazine—HTR2A—conduct disorder	0.00679	0.0362	CrCbGaD
Orphenadrine—Amitriptyline—SLC6A4—conduct disorder	0.00676	0.0361	CrCbGaD
Orphenadrine—Doxepin—HTR2A—conduct disorder	0.00672	0.0359	CrCbGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—COMT—conduct disorder	0.00636	0.0147	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00632	0.0146	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0063	0.0146	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00611	0.0141	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—GABRA2—conduct disorder	0.00604	0.014	CbGpPWpGaD
Orphenadrine—Promazine—HTR2A—conduct disorder	0.00597	0.0319	CrCbGaD
Orphenadrine—HRH1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0059	0.0137	CbGpPWpGaD
Orphenadrine—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00581	0.0134	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00552	0.0128	CbGpPWpGaD
Orphenadrine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00547	0.0127	CbGpPWpGaD
Orphenadrine—Imipramine—HTR2A—conduct disorder	0.00523	0.0279	CrCbGaD
Orphenadrine—Amitriptyline—HTR2A—conduct disorder	0.0052	0.0277	CrCbGaD
Orphenadrine—SLC6A2—NRF2 pathway—SLC6A4—conduct disorder	0.00499	0.0115	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—COMT—conduct disorder	0.00487	0.0113	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—MAOA—conduct disorder	0.00484	0.0112	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00474	0.011	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.00471	0.0109	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0046	0.0106	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00456	0.0105	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.00454	0.0105	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00453	0.0105	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.0045	0.0104	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00387	0.00894	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00375	0.00867	CbGpPWpGaD
Orphenadrine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0037	0.00856	CbGpPWpGaD
Orphenadrine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00362	0.00838	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—COMT—conduct disorder	0.00349	0.00808	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—MAOA—conduct disorder	0.00347	0.00802	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00325	0.00752	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00318	0.00735	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00313	0.00723	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.00307	0.0071	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—COMT—conduct disorder	0.00291	0.00673	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—MAOA—conduct disorder	0.00289	0.00668	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00252	0.00582	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.00251	0.0058	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00245	0.00566	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CGA—conduct disorder	0.00242	0.0056	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00238	0.00551	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.00238	0.00551	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.0022	0.00509	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00208	0.0048	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00205	0.00474	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00204	0.00473	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00199	0.00461	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00199	0.00459	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00198	0.00458	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00197	0.00455	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00195	0.00452	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—COMT—conduct disorder	0.00194	0.00449	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.00193	0.00445	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.00191	0.00442	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00178	0.00412	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00175	0.00406	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00175	0.00405	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00168	0.00389	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00157	0.00363	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.00137	0.00316	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00136	0.00313	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.00136	0.00313	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.00135	0.00311	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00133	0.00308	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.00133	0.00308	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—EP300—conduct disorder	0.00131	0.00302	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.00124	0.00287	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00122	0.00283	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—EP300—conduct disorder	0.0012	0.00278	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00116	0.00269	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—EP300—conduct disorder	0.00116	0.00268	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—EP300—conduct disorder	0.00116	0.00268	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00114	0.00264	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00106	0.00244	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—EP300—conduct disorder	0.000948	0.00219	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.0009	0.00208	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000893	0.00207	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000887	0.00205	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	0.000884	0.00205	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.00087	0.00201	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—EP300—conduct disorder	0.000815	0.00188	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	0.000766	0.00177	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.000754	0.00174	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CGA—conduct disorder	0.00075	0.00173	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CGA—conduct disorder	0.000735	0.0017	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CGA—conduct disorder	0.000734	0.0017	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CGA—conduct disorder	0.000722	0.00167	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—DRD4—conduct disorder	0.000696	0.00161	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.000684	0.00158	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—WASF1—conduct disorder	0.000588	0.00136	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.000579	0.00134	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	0.0005	0.00116	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.000492	0.00114	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	0.000454	0.00105	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.000447	0.00103	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DRD4—conduct disorder	0.000411	0.00095	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.000404	0.000935	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CGA—conduct disorder	0.000341	0.000788	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—COMT—conduct disorder	0.000339	0.000783	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MAOA—conduct disorder	0.000336	0.000778	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—COMT—conduct disorder	0.000332	0.000767	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MAOA—conduct disorder	0.000329	0.000762	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR2A—conduct disorder	0.000268	0.00062	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.000264	0.00061	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—COMT—conduct disorder	0.000154	0.000356	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000153	0.000353	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—EP300—conduct disorder	0.000145	0.000336	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—EP300—conduct disorder	0.000142	0.000329	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EP300—conduct disorder	0.000142	0.000329	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EP300—conduct disorder	0.00014	0.000323	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—EP300—conduct disorder	6.6e-05	0.000153	CbGpPWpGaD
